IBDEI06B ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8236,1,5,0)
 ;;=5^Chr Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,8236,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,8237,0)
 ;;=425.11^^74^623^57
 ;;^UTILITY(U,$J,358.3,8237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8237,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,8237,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,8237,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,8238,0)
 ;;=425.18^^74^623^62
 ;;^UTILITY(U,$J,358.3,8238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8238,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,8238,1,5,0)
 ;;=5^Oth Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,8238,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,8239,0)
 ;;=V12.55^^74^623^52
 ;;^UTILITY(U,$J,358.3,8239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8239,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,8239,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,8239,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,8240,0)
 ;;=271.3^^74^624^17
 ;;^UTILITY(U,$J,358.3,8240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8240,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,8240,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,8240,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,8241,0)
 ;;=611.1^^74^624^22
 ;;^UTILITY(U,$J,358.3,8241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8241,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,8241,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,8241,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,8242,0)
 ;;=704.1^^74^624^23
 ;;^UTILITY(U,$J,358.3,8242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8242,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,8242,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,8242,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,8243,0)
 ;;=251.2^^74^624^36
 ;;^UTILITY(U,$J,358.3,8243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8243,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,8243,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,8243,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,8244,0)
 ;;=257.2^^74^624^37
 ;;^UTILITY(U,$J,358.3,8244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8244,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,8244,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,8244,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,8245,0)
 ;;=253.2^^74^624^41
 ;;^UTILITY(U,$J,358.3,8245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8245,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,8245,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,8245,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,8246,0)
 ;;=733.00^^74^624^52
 ;;^UTILITY(U,$J,358.3,8246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8246,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,8246,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,8246,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,8247,0)
 ;;=278.00^^74^624^48
 ;;^UTILITY(U,$J,358.3,8247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8247,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,8247,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,8247,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,8248,0)
 ;;=278.01^^74^624^47
 ;;^UTILITY(U,$J,358.3,8248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8248,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,8248,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,8248,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,8249,0)
 ;;=250.80^^74^624^15
 ;;^UTILITY(U,$J,358.3,8249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8249,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,8249,1,5,0)
 ;;=5^DM Type II W/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,8249,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,8250,0)
 ;;=250.00^^74^624^9
 ;;^UTILITY(U,$J,358.3,8250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8250,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,8250,1,5,0)
 ;;=5^DM Type II  W/O Complications
 ;;^UTILITY(U,$J,358.3,8250,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,8251,0)
 ;;=250.40^^74^624^11
 ;;^UTILITY(U,$J,358.3,8251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8251,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,8251,1,5,0)
 ;;=5^DM Type II W/ Nephropathy
 ;;^UTILITY(U,$J,358.3,8251,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,8252,0)
 ;;=250.50^^74^624^14
 ;;^UTILITY(U,$J,358.3,8252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8252,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,8252,1,5,0)
 ;;=5^DM Type II W/ PDR
 ;;^UTILITY(U,$J,358.3,8252,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,8253,0)
 ;;=250.60^^74^624^12
 ;;^UTILITY(U,$J,358.3,8253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8253,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,8253,1,5,0)
 ;;=5^DM Type II W/ Neuropathy
 ;;^UTILITY(U,$J,358.3,8253,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,8254,0)
 ;;=250.70^^74^624^13
 ;;^UTILITY(U,$J,358.3,8254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8254,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,8254,1,5,0)
 ;;=5^DM Type II W/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,8254,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,8255,0)
 ;;=250.01^^74^624^8
 ;;^UTILITY(U,$J,358.3,8255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8255,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,8255,1,5,0)
 ;;=5^DM Type I  W/O Complications
 ;;^UTILITY(U,$J,358.3,8255,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,8256,0)
 ;;=272.0^^74^624^28
 ;;^UTILITY(U,$J,358.3,8256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8256,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,8256,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,8256,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,8257,0)
 ;;=272.1^^74^624^33
 ;;^UTILITY(U,$J,358.3,8257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8257,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,8257,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,8257,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,8258,0)
 ;;=272.2^^74^624^30
 ;;^UTILITY(U,$J,358.3,8258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8258,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,8258,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,8258,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,8259,0)
 ;;=275.42^^74^624^27
 ;;^UTILITY(U,$J,358.3,8259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8259,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,8259,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,8259,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,8260,0)
 ;;=275.41^^74^624^35
 ;;^UTILITY(U,$J,358.3,8260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8260,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,8260,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,8260,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,8261,0)
 ;;=276.7^^74^624^29
 ;;^UTILITY(U,$J,358.3,8261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8261,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,8261,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,8261,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,8262,0)
 ;;=275.2^^74^624^25
 ;;^UTILITY(U,$J,358.3,8262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8262,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,8262,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,8262,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,8263,0)
 ;;=276.0^^74^624^31
 ;;^UTILITY(U,$J,358.3,8263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8263,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,8263,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,8263,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,8264,0)
 ;;=276.1^^74^624^38
 ;;^UTILITY(U,$J,358.3,8264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8264,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,8264,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,8264,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,8265,0)
 ;;=275.3^^74^624^26
 ;;^UTILITY(U,$J,358.3,8265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8265,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,8265,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,8265,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,8266,0)
 ;;=240.0^^74^624^20
 ;;^UTILITY(U,$J,358.3,8266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8266,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,8266,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,8266,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,8267,0)
 ;;=241.1^^74^624^19
 ;;^UTILITY(U,$J,358.3,8267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8267,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,8267,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,8267,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,8268,0)
 ;;=241.0^^74^624^59
 ;;^UTILITY(U,$J,358.3,8268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8268,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,8268,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,8268,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,8269,0)
 ;;=242.00^^74^624^21
 ;;^UTILITY(U,$J,358.3,8269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8269,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,8269,1,5,0)
 ;;=5^Graves' Disease
 ;;^UTILITY(U,$J,358.3,8269,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,8270,0)
 ;;=242.01^^74^624^18
 ;;^UTILITY(U,$J,358.3,8270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8270,1,4,0)
 ;;=4^242.01
 ;;^UTILITY(U,$J,358.3,8270,1,5,0)
 ;;=5^Goiter Diff Tox W Strm
 ;;^UTILITY(U,$J,358.3,8270,2)
 ;;=^267794
 ;;^UTILITY(U,$J,358.3,8271,0)
 ;;=252.1^^74^624^40
 ;;^UTILITY(U,$J,358.3,8271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8271,1,4,0)
 ;;=4^252.1
 ;;^UTILITY(U,$J,358.3,8271,1,5,0)
 ;;=5^Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,8271,2)
 ;;=^60635
 ;;^UTILITY(U,$J,358.3,8272,0)
 ;;=242.90^^74^624^32
 ;;^UTILITY(U,$J,358.3,8272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8272,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,8272,1,5,0)
 ;;=5^Hyperthyroid W/O Goiter Or Strm
 ;;^UTILITY(U,$J,358.3,8272,2)
 ;;=^267811
 ;;^UTILITY(U,$J,358.3,8273,0)
 ;;=242.91^^74^624^45
 ;;^UTILITY(U,$J,358.3,8273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8273,1,4,0)
 ;;=4^242.91
 ;;^UTILITY(U,$J,358.3,8273,1,5,0)
 ;;=5^Hyprthy W/O Goit W Strm
 ;;^UTILITY(U,$J,358.3,8273,2)
 ;;=^267812
 ;;^UTILITY(U,$J,358.3,8274,0)
 ;;=244.0^^74^624^43
 ;;^UTILITY(U,$J,358.3,8274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8274,1,4,0)
 ;;=4^244.0
